$ILMN

Leckman Patricia sold $127K of ILMN

Leckman Patricia (SVP, Chief People Officer) sold 783 shares of ILLUMINA, INC. (ILMN) at an average of $162.59 ($161.79–$167.88, $0.13M total) across 5 trades on 2026-06-05 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Leckman Patricia
Published Jun 9, 2026, 8:32 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 9, 2026, 8:38 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ILMN
Neutral
high confidence
Mentioned
$ILMN
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ILMNNeutralLow
01

Why it matters

The disclosure updates the record of insider activity but does not introduce new fundamentals, guidance, litigation, or operational changes.

02

Market read

Primarily a sentiment/positioning datapoint; likely low impact on valuation absent corroborating fundamental news.

03

What to watch

Because it’s explicitly a pre-arranged 10b5-1 plan, the sale timing is less informative than discretionary selling.

Relevance 3/10Novelty 2/10Timing: Filed 2026-06-09 (covers sale dated 2026-06-05).

Background

The article is a primary-source SEC Form 4 insider transaction disclosure (open-market sale) for Illumina.

Company-level read

Ticker impact

$ILMNNeutralHigh confidence
Context

Illumina insider Form 4 shows SVP Chief People Officer Patricia Leckman sold 783 shares for ~$127.3K under a 10b5-1 plan on 2026-06-05.

Expected impact

Low likelihood of sustained price impact; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is an open-market sale by an officer under a pre-arranged 10b5-1 plan, with modest dollar value relative to typical large-cap trading.

Market effects

No direct sector read-through; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

Traders sometimes treat clustered insider sales as a sentiment check; if broader insider selling is occurring, this could reinforce a cautious tape.

Key entities

  • Illumina, Inc.

    Subject of the Form 4 insider sale disclosure.

  • Patricia Leckman

    SVP, Chief People Officer who sold shares under a 10b5-1 plan.

Related articles

$ILMNHighAI 9/10

Illumina (ILMN) Q2 2026 Earnings Call Transcript

Illumina (ILMN) reported Q2 2026 revenue of $1.16B, up 9.5% YoY, and non-GAAP EPS of $1.31. Clinical consumables and NovaSeq X placements drove results. Gross margin was 68.2%. Full-year 2026 guidance was raised to $4.60B-$4.64B revenue and $5.30-$5.40 EPS. Cash was $1.17B vs $1.99B debt.

$ILMNHighAI 9/10

Illumina (ILMN) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Head of Investor Relations - Conor McNamara Chief Executive Officer - Jacob Thaysen Chief Financial Officer - Ankur Dhingra TAKEAWAYS Total Revenue -- $1.16 billion, representing a 9.5% increase year over year driven by clinical market demand and the NovaSeq X expansion. Rest of World Organic Revenue -- Increased 8.1% year over year, exceeding the high end of management's previous guidance.

$ILMNMedAI 8/10

Illumina (NASDAQ:ILMN) Surprises With Q2 CY2026 Sales, Full

Genomics company Illumina (NASDAQ: ILMN) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 9.4% year on year to $1.16 billion. The company’s full-year revenue guidance of $4.62 billion at the midpoint came in 1.1% above analysts’ estimates. Its non-GAAP profit of $1.31 per share was 6.8% above analysts’ consensus estimates. Is now the time to buy Illumina? Find out by accessing our full research report, it’s free.

$ILMNHigh

ILLUMINA, INC. (ILMN): Results of Operations and Financial Condition

ILLUMINA, INC. (ILMN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q226earningsrelease.htm EX-99.1 Document Investors: Conor McNamara +1.858.291.6421 ir@illumina.com Media: Christine Douglass pr@illumina.com Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026 San Diego, July 30, 2026 /PRNewswire/ -- Illumina, Inc.